Announced Fri, 26 Jun · 12:20 IST
Indoco Remedies Goa Plant gets EU GMP certification from Malta authority
INDOCO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+3.9%1-day move
₹231.00
prior close
₹237.99
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.2-0.5-0.2+1.0+3.9+2.8+6.3+5.2+2.2+8.2+6.0———
Up moveDown movePending
AI summary
Indoco Remedies Goa Plant-I, which makes solid oral dosage forms, has received EU GMP certification from the Malta Medicines Authority after an inspection in November 2025. This confirms the plant meets EU Good Manufacturing Practice standards, enabling the company to supply medicines to European markets. Indoco has a turnover of about USD 175 million with 10 manufacturing facilities approved by regulators including USFDA and UK-MHRA.
Likely market impact
Positive for export business to EU markets; expands addressable market and validates quality standards.